Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_assertion type Assertion NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_head.
- NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_assertion description "[Several studies have demonstrated that polymorphisms in the LPIN1 and LPIN2 genes are associated with metabolic disease traits, including insulin sensitivity, diabetes, blood pressure and response to thiazolidinedione drugs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_provenance.
- NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_assertion evidence source_evidence_literature NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_provenance.
- NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_assertion SIO_000772 19369868 NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_provenance.
- NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_assertion wasDerivedFrom befree-20140225 NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_provenance.
- NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_assertion wasGeneratedBy ECO_0000203 NP636263.RAGVFnKABtCNKkoKHqTuFCuWjrpftyIYc8rHEGaki_Zeo130_provenance.